Description:

ECOG Non-Protocol Therapy Form NCT00520975 First-Line Chemotherapy and Trastuzumab With or Without Bevacizumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER-2/NEU Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=1720CDCE-4815-5A14-E044-0003BA3F9857

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=1720CDCE-4815-5A14-E044-0003BA3F9857

Keywords:
Versions (3) ▾
  1. 8/26/12
  2. 1/9/15
  3. 6/16/15
Uploaded on:

June 16, 2015

DOI:
No DOI assigned. To request one please log in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

ECOG Non-Protocol Therapy Form NCT00520975

Details

INSTRUCTIONS: Use this form to capture the first occurrence of non-protocol anti-tumor therapy per registration step

Header
Reporting Period
Patient demographics
Off protocol treatment
Non-protocol Chemotherapy
Non-protocol Hormonal Therapy
Non-protocol Immunotherapy (Biological Response Modifiers)
Non-protocol High Dose Chemotherapy/Stem Cell Transplant (Autologous or Allogeneic)
Non-protocol Surgery
Non-protocol Radiation Therapy
Other Non-protocol Therapy
Was the non-protocol therapy given for the disease of this protocol (NOTE: Treatment for a second primary in the same organ site would not be considered therapy for disease of this protocol.)
Comments
Back to the top of the page 

Similar models